Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 6
Journal homepage
525
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Possible preventive effect of salazosulfapyridine against development of Pneumocystis pneumonia in methotrexate-receiving patients with rheumatoid arthritis

Kennosuke MizushinaDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Ayako HirataDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Norihide HayashiDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Sayaka TakenakaDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Hideki ItoDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Takehisa OguraDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Yuki FujisawaDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Munetsugu ImamuraDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Naoko YamashitaDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Rie KujimeDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
,
Sumie NakahashiDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, Japan
&
Hideto KamedaDivision of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Meguro-ku, Tokyo, JapanCorrespondence[email protected] [email protected]
 show all
Pages 976-978 | Received 03 Aug 2015, Accepted 05 Nov 2015, Published online: 23 Dec 2015

References

  • Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, et al. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study. Intern Med. 2008;47:915–23.
  • Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka Het al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:189–94.
  • Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, et al. Postmarketing surveillance of the safety and effectiveness of etanercept in Japan. J Rheumatol. 2009;36:898–906.
  • Atsumi T, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, et al. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naïve early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression. Ann Rheum Dis. [Epub ahead of print]. doi:10.1136/annrheumdis-2015-207511.
  • Harigai M, Koike R, Miyasaka N; Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med. 2007;357:1874–6.
  • Katsuyama T, Saito Y, Kubo S, Nawata M, Tanaka Y. Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. Arthritis Res Ther. 2014;16:R43.
  • Mitsides N, Greenan K, Green D, Middleton R, Lamerton E, Allen J, et al. Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for Pneumocystis pneumonia in renal transplant recipients. Nephrology. 2014;19:157–63.
  • Plosker GL, Croom KF. Sulfasalazine: a review of its use in the management of rheumatoid arthritis. Drug. 2005;65:1825–49.
  • Wang J, Gigliotti F, Bhagwat SP, George TC, Wright TW. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia. PLoS Pathog. 2010;6:e1001058.
  • Komano Y, Harigai M, Koike R, Sugiyama H, Ogawa J, Saito K, et al. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Rheum. 2009;61:305–12.
  • Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, et al. Serum indicators for the diagnosis of Pneumocystis pneumonia. Chest. 2007;131:1173–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.